Acquisition Indo-National Limited has informed the Exchange about Acquisition Indo-National Limited has informed the Exchange about Acquisition
Company Update Intimation for approval of Investment of 74% of Equity Shares in the Proposed Company '''' Avanir Wellness Resorts Private Limited'''' by the Board of Directors of the Company at its Meeting held on 29th May, 2026. Intimation for approval of Investment of 74% of Equity Shares in the Proposed Company '''' Avanir Wellness Resorts Private Limited'''' by the Board of Directors of the Company at its Meeting held on 29th May, 2026.
Company Update Intimation for approval of Investment of 74% of Equity Shares in the Proposed Company '''' Avanir Wellness Resorts Private Limited'''' by the Board of Directors of the Company at its Meeting held on 29th May, 2026. Intimation for approval of Investment of 74% of Equity Shares in the Proposed Company '''' Avanir Wellness Resorts Private Limited'''' by the Board of Directors of the Company at its Meeting held on 29th May, 2026.
Outcome of Board Meeting Dhampur Bio Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Dhampur Bio Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting Dhampur Bio Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Dhampur Bio Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Corp. Action Corporate Action-Record date fixed on 14-09-2026 for the purpose of payment of Dividend to be approved in 35th AGM dated 21/09/2026 Corporate Action-Record date fixed on 14-09-2026 for the purpose of payment of Dividend to be approved in 35th AGM dated 21/09/2026
Corp. Action Corporate Action-Record date fixed on 14-09-2026 for the purpose of payment of Dividend to be approved in 35th AGM dated 21/09/2026 Corporate Action-Record date fixed on 14-09-2026 for the purpose of payment of Dividend to be approved in 35th AGM dated 21/09/2026
Company Update Submission of Transcript of Earnings Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31.03.2026. Submission of Transcript of Earnings Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31.03.2026.
Company Update Submission of Transcript of Earnings Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31.03.2026. Submission of Transcript of Earnings Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31.03.2026.
Company Update Newspaper Publication of Financial Results for the quarter and year ended on March 31, 2026 is attached herewith Newspaper Publication of Financial Results for the quarter and year ended on March 31, 2026 is attached herewith
Company Update Newspaper Publication of Financial Results for the quarter and year ended on March 31, 2026 is attached herewith Newspaper Publication of Financial Results for the quarter and year ended on March 31, 2026 is attached herewith
Investor Presentation Concord Biotech Limited has informed the Exchange about Investor Presentation Concord Biotech Limited has informed the Exchange about Investor Presentation
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
Need more? Pro tracks up to 500 companies with preferential issue alerts.
No credit card required. Connect WhatsApp or Telegram in minutes.